| Name | Epertinib hydrochloride |
|---|
| Description | Epertinib hydrochloride is a potent, orally active, reversible, and selective tyrosine kinase inhibitor of EGFR, HER2 and HER4, with IC50s of 1.48 nM, 7.15 nM and 2.49 nM, respectively. Epertinib shows potent antitumor activity[1]. |
|---|---|
| Related Catalog | |
| Target |
EGFR:1.48 nM (IC50) HER4:2.49 nM (IC50) HER2:7.15 nM (IC50) |
| References |
| Molecular Formula | C30H28Cl2FN5O3 |
|---|---|
| Molecular Weight | 596.48 |